Data Support Continued Access to Tecovirimat for Monkeypox

MONDAY, Sept. 12, 2022 -- The data support continued access to tecovirimat for treatment of monkeypox virus infection, with subjective improvement seen at a median of three days after initiation of treatment, according to research published in the...